A recent study reveals that people who discontinue blockbuster slimming jabs like Mounjaro or Wegovy can put back on reduced body mass at a significantly accelerated pace than those who stop conventional lifestyle plans.
Findings released in a prominent health publication shows that while obese people frequently drop substantial amounts of their total mass while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"Individuals buying these drugs need to be cognizant of the risk of quick rebound weight gain when the therapy ends," warns expert Dr. Susan Jebb.
Such speed of regain suggests a reversion to original mass in about one and a half years.
Analyzing Treatments
The analysis, which examined 37 of studies involving thousands of participants, compared the results of GLP-1 agonists with conventional dieting.
Scientists note that people who shed pounds through lifestyle changes alone usually experience a less rapid weight regain—around 0.1 kg a month—after stopping.
Explaining the Quick Rebound
Nutrition scientists believe the mechanism of the injections accounts for the accelerated weight return.
The injections imitate a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing the hormone levels far above than normal might result in the body to generate a reduced amount of its own natural hormone, and could reduce sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication results in appetite is uncontrolled, making overeating far more likely."
A Chronic Condition?
Health authorities suggest the injections for people with obesity-related health risks, alongside prescribed diet and exercise modifications.
Many experts contend that, considering the likelihood of weight regain, the treatment is often life-long.
This perspective is reinforced by pharmaceutical companies, who say that the findings "highlight the persistent nature of obesity," similar to managing conditions like hypertension.
User Testimonies
Users who have discontinued the jabs report a intense resurgence of appetite.
"It felt as if a trigger flipping and you're instantly extremely hungry," said one woman.
This difficulty is worsened if users have not developed lasting dietary or behavioural modifications during treatment.
Widespread Adoption
Survey data suggest that a significant number of adults in the UK have used these injections in the past year, with interest remaining high.
- Adoption is more common among women compared to men.
- The 40s and 50s demographic shows the highest usage rates.
- Many access the medications through private prescriptions rather than public health services.
In conclusion, clinicians caution that while these medications are effective tools for shedding pounds, they are not a standalone cure and long-term success relies on integrated lifestyle support.
